Researchers found lowering TPPP3 may make ovarian cancer more sensitive to cisplatin, improving chemotherapy’s effectiveness.

A gastrointestinal oncologist told Newsweek that the early-stage findings are a “major step forward” in targeting colon ...

The collaboration will use Immunai’s single-cell AI platform to identify T-cell targets in cancer and autoimmune diseases.

Researchers created a DIA-MS atlas of 13,609 proteins across 2,856 samples from fetal, healthy adult, paired non-tumor, and ...

The collaboration will see the companies gather and analyse data from many patient samples.

Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have identified a molecule on the surface of cells that could be a promising therapeutic target against cancer.

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new platform that combines 3D bioprinting ...

A discovery by the Transformation and Metastasis Group of the Spanish National Cancer Research Center (CNIO) opens a path towards identifying precancerous breast lesions that will develop into tumors.

Colorectal cancer (CRC) is a leading cause of cancer-related mortality, necessitating the development of novel therapeutic strategies. In the present study, we identified TP53-regulating kinase ...

Fluorescently labeled cell showing the cell body in green, the cytoskeleton in blue, the cell nucleus in yellow, and actin focal-adhesion rings wrapped around surface-fixed particles. New study shows ...

Targeted therapies show promising initial responses in non-small-cell lung cancer (NSCLC) with actionable genetic alterations; however, these responses are often incomplete and temporary 1.